SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-20-023119
Filing Date
2020-08-20
Accepted
2020-08-20 17:00:12
Documents
1
Period of Report
2020-07-10

Document Format Files

Seq Description Document Type Size
1 ownership.html 3/A  
1 ownership.xml 3/A 2700
  Complete submission text file 0001213900-20-023119.txt   4091
Mailing Address C/O PHARMATHENE, INC., ONE PARK PLACE SUITE 450 ANNAPOLIS MD 21401
Business Address
Runge Jeffrey W. (Reporting) CIK: 0001479091 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39336 | Film No.: 201120656

Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Issuer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations